ArticleVaccines2023

Antibody Response Following the Intranasal Administration of SARS-CoV-2 Spike Protein-CpG Oligonucleotide Vaccine.

Kentaro Muranishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.